Delivery Order SPE2DX22D0030-SPE2D826F0CA2
- Not listed
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $903,311.36 to AmerisourceBergen Drug Corp on November 15, 2025, with an ultimate completion date of November 17, 2025. This firm fixed-price, non-set-aside delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $1 billion and extending through December 2026. The delivery order is being performed...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $228,023.12 to AmerisourceBergen Drug Corp on August 13, 2025, for pharmaceutical and medical supply delivery. This firm fixed-price, non-competitive delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $1 billion through December 2026. The work will be performed at the company's Corporate...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $343,401.38 to AmerisourceBergen Drug Corp on November 5, 2025, with an ultimate completion date of November 6, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $1 billion through December 2026. The delivery order will be fulfilled at the...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $5,407.24 to AmerisourceBergen Drug Corp on November 10, 2025, with an ultimate completion date of November 12, 2025. This firm fixed price, non-competitive delivery order (No. 4569972654) is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $1 billion through December 2026. The work will be performed at the...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $2,144.37 to AmerisourceBergen Drug Corp on June 9, 2025, with completion expected by June 10, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $1 billion through December 2026. The contract was competitively awarded to...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a firm fixed-price delivery order valued at $10,750.82 to AmerisourceBergen Drug Corp on December 8, 2025, with an ultimate completion date of December 9, 2025. This non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 through December 2026. AmerisourceBergen, a major...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $119,950.23 to AmerisourceBergen Drug Corp on September 18, 2025, with completion targeted for the same date. This firm fixed-price, competitively awarded delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $1 billion pharmaceutical support vehicle extending through December 2026. The delivery order will be...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $25,740.22 to AmerisourceBergen Drug Corp on December 8, 2025, with completion expected by December 9, 2025. This non-competitive, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. The order will be fulfilled from...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $5,783.04 to AmerisourceBergen Drug Corp on November 18, 2025, with completion scheduled for November 19, 2025. This firm fixed-price, non-competitive delivery order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $1 billion and extending through December 2026. AmerisourceBergen, headquartered in Conshohocken,...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $31,651.86 to AmerisourceBergen Drug Corp on November 10, 2025, with an ultimate completion date of November 12, 2025. This firm fixed-price, non-set-aside delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $1 billion and extending through December 2026. The work is being performed at the company's...
- SPE2DX22D0030Indefinite Delivery Contract
- SPE2DX22D0030-SPE2D826F0CA2Delivery Order
The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $1,026.72 to AmerisourceBergen Drug Corp on November 25, 2025, with completion expected by November 26, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $1 billion through December 2026. The contract was competitively awarded with no set-aside designation and is performed from the company's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, supplies a comprehensive portfolio of pharmaceutical products and medical supplies to support military and federal healthcare systems. As a prime vendor under the DLA Troop Support Medical contract, the company delivers brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. This particular delivery order reflects the company's ongoing role as a critical supplier within the federal medical procurement infrastructure, serving entities including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 11/24/25 |